DrAbhiPal Profile Banner
Abhijit Pal Profile
Abhijit Pal

@DrAbhiPal

Followers
975
Following
7K
Media
113
Statuses
2K

Medical oncologist - early phase trials, lung cancer, diversity/inclusion, trainee welfare @Sydney_Uni @SWSLHD @NHMRC - ex @royalmarsdenNHS - views are my own

Sydney, Australia
Joined September 2011
Don't wanna be here? Send us removal request.
@DrAbhiPal
Abhijit Pal
9 months
Happy to share our editorial about structural racism and inequity in cancer trials - - inequity is baked into the system. Time for greater uptake of solutions (Table 1) at site and sponsor level to improve equity @cancer_K2A @Dr_RSMoussa @DKarikios
Tweet media one
Tweet media two
1
8
21
@DrAbhiPal
Abhijit Pal
15 days
RT @Drdhadams: #ANZUP2025 fantastic talks on mentorship acknowledging ⁦@MOGA_ORG⁩ ⁦mentorship program 👏
Tweet media one
0
3
0
@DrAbhiPal
Abhijit Pal
1 month
RT @AOParsonson: Congratulations to the incoming new YOGA National Committee Members! Following a competitive selection process, the follow….
0
4
0
@DrAbhiPal
Abhijit Pal
1 month
RT @StephenVLiu: FDA grants accelerated approval for datopotamab deruxtecan, anti-TROP2 ADC, for #EGFR mutant NSCLC after prior TKI and che….
Tweet card summary image
ascopost.com
The FDA approved the agent for adults with locally advanced or metastatic EGFR-mutated NSCLC who have received prior EGFR-directed therapy and platinum-based chemotherapy.
0
33
0
@DrAbhiPal
Abhijit Pal
2 months
RT @oncodaily: Evaluating Patient Diversity in Early Phase Clinical Trials in Australia - Abhijit Pal.@DrAbhiPal . .
0
1
0
@DrAbhiPal
Abhijit Pal
2 months
RT @DrRiyazShah: Simple message about CPI duration in 1st line NSCLC #ASCO25
Tweet media one
0
5
0
@DrAbhiPal
Abhijit Pal
2 months
RT @neerajaiims: Ab#5015 @ASCO #ASCO25 by @AOParsonson 👉�Ph1/2 study of novel B7-H3-targeting ADC (DB 1311/BNT324) i….
0
25
0
@DrAbhiPal
Abhijit Pal
2 months
RT @VriesElisabeth: Very happy to be able to share with you that the ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0)….
0
10
0
@DrAbhiPal
Abhijit Pal
3 months
RT @docranjana: The cost of getting care and getting there: why is hospital parking so expensive in Australia? | Ranjana Srivastava | The G….
Tweet card summary image
theguardian.com
By now, Australians know ‘free’ healthcare is not really free. Easing the cost of parking would be a practical way of helping patients
0
3
0
@DrAbhiPal
Abhijit Pal
3 months
RT @cancerNSW: It’s international #ClinicalTrialsDay. We acknowledge our research partnerships and everyone involved in testing new treatme….
0
2
0
@DrAbhiPal
Abhijit Pal
3 months
RT @The_IMJ: IMJ May 2025 #FreeAccess .Editorial: The pre-round: What are Junior Doctors doing before handover?.@Th….
0
4
0
@DrAbhiPal
Abhijit Pal
3 months
RT @MacLeanEthics: Join us for the final Advocacy in Healthcare and Medicine lecture: "The Occasional Human Sacrifice: Medical Experimentat….
0
1
0
@DrAbhiPal
Abhijit Pal
4 months
RT @PeterMacCC: Researchers from Peter Mac will collaborate with colleagues across Australia to evaluate the use of serial liquid biopsies….
0
4
0
@DrAbhiPal
Abhijit Pal
4 months
RT @Sabesan68: Touching story of Dr Lynham’s family. In a country like ours, everyone should have access to clinical trials. More money and….
Tweet card summary image
abc.net.au
As Australians face roadblocks to find clinical trials, doctors are calling for a reform of the system to improve access to potentially life-saving studies.
0
4
0
@DrAbhiPal
Abhijit Pal
4 months
RT @SquigglyRick: “They were unsure whether the conversation we had was real or a dream. so wanted to make sure the advice was correct.”….
thesaturdaypaper.com.au
Letters from the NSW government threatening disciplinary action against doctors striking for better pay and conditions have encouraged walkouts on an unprecedented scale.
0
83
0
@DrAbhiPal
Abhijit Pal
4 months
RT @ramsedhom: lol reading this piece by David Johnston - some deep truths
Tweet card summary image
ascopubs.org
0
2
0
@DrAbhiPal
Abhijit Pal
4 months
RT @CancerEthicsDoc: ⭐️ NEW PUBLICATION⭐️In 2024 @iaslc's JTO published a debate on the role of #equipoise in Ph3 RCTs of precision oncolog….
0
1
0